Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04401332 · ClinicalTrials.gov registry record · NA
A Randomized Controlled Trial of AppS to Home Monitor Your Asthma
A NA study of Asthma, sponsored by RAND.
- Completed
- Registry status
- NA
- Development phase
- 445
- Enrollment target
- 1
- Study location
NCT04401332: Completed NA study of Asthma, sponsored by RAND.
NCT04401332 is a NA study of Asthma that has completed, run by RAND. The registered enrollment target is 445 participants, below the 1,562-participant average among 374 other Asthma trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04401332, a NA study of Asthma, has completed, sponsored by RAND.
- COMPLETED
- Registry status
- NA
- Development phase
- 445 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to design, implement, and evaluate the impact of an adapted health information technology(IT)-enabled practice model for asthma symptom monitoring using patient-reported outcomes (PROs) in a primary care setting. Adults over 18 years of age with asthma will be recruited at primary care clinics and randomized to either 1) asthma symptom monitoring via the mobile health (mHealth) app; or 2) usual care. The investigators will collect data on patient-reported asthma quality of life and asthma-related healthcare utilization. We will also study barriers and facilitators to implementation of the mHealth app and health IT-enabled practice model.
Primary Outcome
Mean change in asthma-related patient-reported quality of life from baseline to 12 months, assessed using the 15-item Mini Asthma Quality of Life Questionnaire (MiniAQLQ). MiniAQLQ scores range from 1 (worst quality of life) to 7 (best quality of life), with higher scores indicating better asthma-related quality of life. The MiniAQLQ score represents the mean of 15 items across four domains (symptoms, activity limitation, emotional function, and environmental stimuli).
Conditions Studied
Interventions
- OTHER mobile health app
Study Locations (1)
Massachusetts
- Brigham & Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 445 participants |
| Start Date | 2020-07-21 |
| Est. Completion | 2023-04-30 |
| Phase | NA |
What the finished NCT04401332 record still lists
NCT04401332 is an interventional study that assigns participants to a tested intervention. The registered 445 participants enrollment target is mid-sized for trials with a published cap, below the 1,562-participant average among 374 other Asthma trials with a reported enrollment target (72% lower).
The record links to 1 condition, with Asthma appearing as the primary indexed condition, and to 1 intervention - of which mobile health app is the first listed.
NCT04401332 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT04401332 about?
NCT04401332 is a clinical study titled "A Randomized Controlled Trial of AppS to Home Monitor Your Asthma". The objective of this study is to design, implement, and evaluate the impact of an adapted health information technology(IT)-enabled practice model for asthma symptom monitoring using patient-reported outcomes (PROs) in a primary care setting. Adults over 18 years of age with asthma will be recruite...
What is the current status of trial NCT04401332?
This trial is currently completed. It is a NA study. The enrollment target is 445 participants. The study started on 2020-07-21. Estimated completion is 2023-04-30.
What conditions does trial NCT04401332 study?
This clinical trial studies the following conditions: Asthma.
What interventions are being tested in trial NCT04401332?
The interventions under investigation include: mobile health app (OTHER).
Who is sponsoring clinical trial NCT04401332?
This trial is sponsored by RAND, which has 78 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04401332 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04401332's enrollment target sits among peer trials
445 84th of 374 higher than 291 of 374 other Asthma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Asthma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Automated Inhaler Monitoring for Asthma Medication Usage
RECRUITING · NA
-
Reducing Overuse of Antibiotics With Decision Support
RECRUITING · NA
-
ASTHMAXcel Voice Study
RECRUITING · NA
-
Home Hospital for Suddenly Ill Adults
RECRUITING · NA
-
Asthma and Technology in Emerging African American Adults
RECRUITING · NA
-
BREATHE: An Efficacy-implementation Trial Among Black Adults With Uncontrolled Asthma
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01280994 · 445 participants · Phase 2
Hyperpolarized 129Xe MRI for Imaging Pulmonary Function
- NCT03504800 · 445 participants
OCT in Diagnosis of Irregular Corneas
- NCT04751435 · 445 participants · NA
Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients
- NCT06348394 · 444 participants · NA
Intracardiac Versus Transesophageal Echocardiographic Guidance for Left Atrial Appendage Occlusion
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI